Authors:
FALLAT ME
SIOW Y
KLAR EA
BELKER AM
MACLAUGHLIN DT
Citation: Me. Fallat et al., THE PRESENCE OF MULLERIAN-INHIBITING SUBSTANCE BINDING-SITES IN HUMANSPERM, The Journal of urology, 159(6), 1998, pp. 2210-2214
Authors:
LEE MM
DONAHOE PK
SILVERMAN BL
HASEGAWA T
HASEGAWA Y
GUSTAFSON ML
CHANG YC
MACLAUGHLIN DT
Citation: Mm. Lee et al., MEASUREMENTS OF SERUM MULLERIAN-INHIBITING SUBSTANCE IN THE EVALUATION OF CHILDREN WITH NONPALPABLE GONADS, The New England journal of medicine, 336(21), 1997, pp. 1480-1486
Authors:
LEE MM
GUSTAFSON ML
SILVERMAN BL
HASEGAWA T
HASEGAWA Y
DONAHOE PK
MACLAUGHLIN DT
Citation: Mm. Lee et al., MULLERIAN-INHIBITING SUBSTANCE (MIS) DETERMINATION IN THE EVALUATION OF NONPALPABLE GONADS, Pediatric research, 39(4), 1996, pp. 534-534
Authors:
MAGGARD MA
CATLIN EA
HUDSON PL
DONAHOE PK
MACLAUGHLIN DT
Citation: Ma. Maggard et al., REDUCTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR PHOSPHORYLATION BY ACTIVATED MULLERIAN-INHIBITING SUBSTANCE IS VANADATE-SENSITIVE, Metabolism, clinical and experimental, 45(2), 1996, pp. 190-195
Authors:
LEE MM
DONAHOE PK
HASEGAWA T
SILVERMAN B
CRIST GB
BEST S
HASEGAWA Y
NOTO RA
SCHOENFELD D
MACLAUGHLIN DT
Citation: Mm. Lee et al., MULLERIAN-INHIBITING SUBSTANCE IN HUMANS - NORMAL LEVELS FROM INFANCYTO ADULTHOOD, The Journal of clinical endocrinology and metabolism, 81(2), 1996, pp. 571-576
Authors:
TEIXEIRA J
HE WW
SHAH PC
MORIKAWA N
LEE MM
CATLIN EA
HUDSON PL
WING J
MACLAUGHLIN DT
DONAHOE PK
Citation: J. Teixeira et al., DEVELOPMENTAL EXPRESSION OF A CANDIDATE MULLERIAN-INHIBITING SUBSTANCE TYPE-II RECEPTOR, Endocrinology, 137(1), 1996, pp. 160-165
Citation: Ms. Kurian et al., CLEAVAGE OF MULLERIAN-INHIBITING SUBSTANCE ACTIVATES ANTIPROLIFERATIVE EFFECTS IN-VIVO, Clinical cancer research, 1(3), 1995, pp. 343-349
Authors:
PRAKASH P
OZTURK E
MACLAUGHLIN DT
SCHIFF I
LOUGHLIN KR
AGARWAL A
Citation: P. Prakash et al., INTERLABORATORY INTERPROTOCOL COMPARISON OF INDIRECT IMMUNOBEAD ASSAYFOR SPERM-ASSOCIATED ANTIBODIES IN SERUM, Archives of andrology, 34(3), 1995, pp. 133-139
Authors:
PULS LE
HAMOUS J
MORROW MS
SCHNEYER A
MACLAUGHLIN DT
CASTRACANE VD
Citation: Le. Puls et al., RECURRENT OVARIAN SEX CORD TUMOR WITH ANNULAR TUBULES - TUMOR-MARKER AND CHEMOTHERAPY EXPERIENCE, Gynecologic oncology, 54(3), 1994, pp. 396-401
Authors:
LEE MM
GUSTAFSON ML
UKIYAMA E
DONAHOE PK
MACLAUGHLIN DT
WEXLER M
KEEPING HS
Citation: Mm. Lee et al., DEVELOPMENTAL-CHANGES IN MULLERIAN-INHIBITING SUBSTANCE IN THE CYNOMOLGUS MONKEY, MACACA-FASCICULARIS, The Journal of clinical endocrinology and metabolism, 78(3), 1994, pp. 615-621
Authors:
HUDSON PL
PEDERSEN WA
SALTSMAN WS
LISCOVITCH M
MACLAUGHLIN DT
DONAHOE PK
BLUSZTAJN JK
Citation: Pl. Hudson et al., MODULATION BY SPHINGOLIPIDS OF CALCIUM SIGNALS EVOKED BY EPIDERMAL GROWTH-FACTOR, The Journal of biological chemistry, 269(34), 1994, pp. 21885-21890
Authors:
HIROBE S
HE WW
GUSTAFSON ML
MACLAUGHLIN DT
DONAHOE PK
Citation: S. Hirobe et al., MULLERIAN-INHIBITING SUBSTANCE GENE-EXPRESSION IN THE CYCLING RAT OVARY CORRELATES WITH RECRUITED OR GRAAFIAN FOLLICLE SELECTION, Biology of reproduction, 50(6), 1994, pp. 1238-1243
Citation: Ea. Catlin et al., MULLERIAN-INHIBITING SUBSTANCE - NEW PERSPECTIVES AND FUTURE-DIRECTIONS, Microscopy research and technique, 25(2), 1993, pp. 121-133